FDA Approves Self-Administered Nasal Flu Vaccine

The U.S. Food and Drug Administration's White Oak campus in Silver Spring, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The U.S. Food and Drug Administration (FDA) has approved an AstraZeneca nasal flu vaccine that can be self-administered or administered by an adult caregiver without a health care provider being present.

On Sept. 20, the FDA announced that FluMist has been approved for the prevention of influenza subtypes A and B in individuals ages 2 to 49 years old.